Kristen Minogue
About Kristen Minogue
Kristen Minogue serves as the Vice President at BGB Group, where she leads a team focused on providing training solutions for pharmaceutical products. With extensive experience in instructional design and project management, she has held various roles in the pharmaceutical industry, including positions at WCG, Red Nucleus, and Bristol Myers Squibb.
Current Role at BGB Group
Kristen Minogue serves as Vice President at BGB Group, a position she has held since 2023. In this role, she leads a full-service team dedicated to delivering training solutions for pharmaceutical products and devices. Her leadership focuses on ensuring that the training solutions provided meet the needs of clients in the pharmaceutical industry.
Previous Experience at WCG
Prior to her current role, Kristen Minogue worked at WCG as the Director of Learning and Professional Development from 2015 to 2018. During her tenure, she was responsible for overseeing learning initiatives and professional development programs. Before that, she served as Global Training Manager at WCG ePharmaSolutions from 2014 to 2015, where she managed training efforts on a global scale.
Background in Pharmaceutical Training
Kristen Minogue has extensive experience in the pharmaceutical sector, having held various roles at Bristol Myers Squibb from 2000 to 2007. Her positions included Clinical Trial Associate, Clinical Systems Analyst, and Learning Specialist. She also worked at Bioclinica in multiple training roles from 2007 to 2013, where she contributed to the development and delivery of training programs.
Education and Qualifications
Kristen Minogue studied at Shippensburg University of Pennsylvania and Villanova University. Her educational background supports her expertise in instructional design and training within the pharmaceutical industry, equipping her with the skills necessary to develop effective learning programs.
Expertise in Instructional Design
Kristen Minogue has a strong background in instructional design, which has enabled her to contribute to innovative learning programs tailored for the pharmaceutical industry. She has successfully executed requests for proposals and presented training solutions for leading pharmaceutical and biotech clients, demonstrating her ability to address diverse therapeutic areas.